Chao Tung Wen
Directeur/Membre du Conseil chez TATUNG SYSTEM TECHNOLOGIES INC.
Profil
Chao Tung Wen is an Independent Director at Tatung System Technologies, Inc. and a Professor at National Chengchi University.
He previously held positions as Chairman at Eastern Ad, and as an Independent Director at E Ink Holdings, Inc. and PharmaDax Inc. Dr. Wen holds an MBA from the University of Rochester, a doctorate from Rensselaer Polytechnic Institute, and an undergraduate degree from Tunghai University.
Postes actifs de Chao Tung Wen
| Sociétés | Poste | Début |
|---|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Directeur/Membre du Conseil | 24/06/2013 |
| National Chengchi University | Corporate Officer/Principal | - |
Anciens postes connus de Chao Tung Wen
| Sociétés | Poste | Fin |
|---|---|---|
| E INK HOLDINGS INC. | Directeur/Membre du Conseil | - |
| Eastern Ad | Président | - |
| PHARMADAX INC. | Directeur/Membre du Conseil | - |
Formation de Chao Tung Wen
| Rochester Christian University | Masters Business Admin |
| Rensselaer Polytechnic Institute | Doctorate Degree |
| Tunghai University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Commercial Services |
| E INK HOLDINGS INC. | Electronic Technology |
| Entreprise privées | 2 |
|---|---|
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
| Eastern Ad |
